This inventor holds 1 USPTO granted patent. Top assignees: Juntendo Educational Foundation, Riken Corporation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 24 
1 out of 892 
Years Active: 2020
Title: Keiko Mitani: Innovator in Lung Cancer Differentiation
Introduction
Keiko Mitani is a prominent inventor based in Bunkyo-ku, Japan. She has made significant contributions to the field of medical diagnostics, particularly in the differentiation of lung cancer types. Her innovative approach aims to enhance the accuracy and speed of cancer diagnosis.
Latest Patents
Keiko Mitani holds a patent for a method that differentiates between lung squamous cell carcinoma and lung adenocarcinoma. This patent provides an approach for objectively and rapidly determining the histological type of a lung cancer lesion with high accuracy. The method involves measuring the expression level of a DNA product in a biological sample collected from the lesion, focusing on specific nucleotide sequences.
Career Highlights
Throughout her career, Keiko Mitani has worked with notable organizations, including the Juntendo Educational Foundation and Riken Corporation. Her work has been instrumental in advancing cancer research and diagnostics.
Collaborations
Keiko has collaborated with esteemed colleagues such as Kazuya Takamochi and Kenji Suzuki. Their combined expertise has contributed to the development of innovative solutions in the medical field.
Conclusion
Keiko Mitani's contributions to lung cancer differentiation exemplify her dedication to improving medical diagnostics. Her innovative methods and collaborations continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile